189 related articles for article (PubMed ID: 34513315)
21. A human IgE bispecific antibody shows potent cytotoxic capacity mediated by monocytes.
Vukovic N; Halabi S; Russo-Cabrera JS; Blokhuis B; Berraondo P; Redegeld FAM; Zaiss DMW
J Biol Chem; 2022 Aug; 298(8):102153. PubMed ID: 35718062
[TBL] [Abstract][Full Text] [Related]
22. AllergoOncology: High innate IgE levels are decisive for the survival of cancer-bearing mice.
Singer J; Achatz-Straussberger G; Bentley-Lukschal A; Fazekas-Singer J; Achatz G; Karagiannis SN; Jensen-Jarolim E
World Allergy Organ J; 2019; 12(7):100044. PubMed ID: 31388397
[TBL] [Abstract][Full Text] [Related]
23. Multiple chimeric antigen receptors successfully target chondroitin sulfate proteoglycan 4 in several different cancer histologies and cancer stem cells.
Beard RE; Zheng Z; Lagisetty KH; Burns WR; Tran E; Hewitt SM; Abate-Daga D; Rosati SF; Fine HA; Ferrone S; Rosenberg SA; Morgan RA
J Immunother Cancer; 2014; 2():25. PubMed ID: 25197555
[TBL] [Abstract][Full Text] [Related]
24. Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding.
Borrok MJ; Luheshi NM; Beyaz N; Davies GC; Legg JW; Wu H; Dall'Acqua WF; Tsui P
MAbs; 2015; 7(4):743-51. PubMed ID: 25970007
[TBL] [Abstract][Full Text] [Related]
25. MicroPET/CT imaging of patient-derived pancreatic cancer xenografts implanted subcutaneously or orthotopically in NOD-scid mice using (64)Cu-NOTA-panitumumab F(ab')2 fragments.
Boyle AJ; Cao PJ; Hedley DW; Sidhu SS; Winnik MA; Reilly RM
Nucl Med Biol; 2015 Feb; 42(2):71-7. PubMed ID: 25456837
[TBL] [Abstract][Full Text] [Related]
26. Antigen mimicry as an effective strategy to induce CSPG4-targeted immunity in dogs with oral melanoma: a veterinary trial.
Riccardo F; Tarone L; Camerino M; Giacobino D; Iussich S; Barutello G; Arigoni M; Conti L; Bolli E; Quaglino E; Merighi IF; Morello E; Dentini A; Ferrone S; Buracco P; Cavallo F
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35580930
[TBL] [Abstract][Full Text] [Related]
27. Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.
Wong JY; Chu DZ; Yamauchi D; Odom-Maryon TL; Williams LE; Liu A; Esteban JM; Wu AM; Primus FJ; Beatty JD; Shively JE; Raubitschek AA
J Nucl Med; 1998 Dec; 39(12):2097-104. PubMed ID: 9867150
[TBL] [Abstract][Full Text] [Related]
28. CSPG4: a prototype oncoantigen for translational immunotherapy studies.
Rolih V; Barutello G; Iussich S; De Maria R; Quaglino E; Buracco P; Cavallo F; Riccardo F
J Transl Med; 2017 Jul; 15(1):151. PubMed ID: 28668095
[TBL] [Abstract][Full Text] [Related]
29. IgE glycans promote anti-IgE IgG autoantibodies that facilitate IgE serum clearance
Plattner K; Gharailoo Z; Zinkhan S; Engeroff P; Bachmann MF; Vogel M
Front Immunol; 2022; 13():1069100. PubMed ID: 36544773
[TBL] [Abstract][Full Text] [Related]
30. Oral tolerance induced to house dust mite extract in naive and sensitized mice: evaluation of immunoglobulin G anti-immunoglobulin E autoantibodies and IgG-IgE complexes.
Sato MN; Carvalho AF; Silva AO; MacIel M; Fusaro AE; Duarte AJ
Immunology; 1998 Oct; 95(2):193-9. PubMed ID: 9824475
[TBL] [Abstract][Full Text] [Related]
31. Lol p I-specific IgE and IgG synthesis by peripheral blood mononuclear cells from atopic subjects in SCID mice.
Gagnon R; Boutin Y; Hébert J
J Allergy Clin Immunol; 1995 Jun; 95(6):1268-75. PubMed ID: 7797796
[TBL] [Abstract][Full Text] [Related]
32. Antigen-independent suppression of the IgE immune response to bee venom phospholipase A2 by maternally derived monoclonal IgG antibodies.
Seeger M; Thierse HJ; Lange H; Shaw L; Hansen H; Lemke H
Eur J Immunol; 1998 Jul; 28(7):2124-30. PubMed ID: 9692881
[TBL] [Abstract][Full Text] [Related]
33. SPECT imaging of neuropilin receptor type-1 expression with 131I-labeled monoclonal antibody.
Dou X; Yan J; Zhang Y; Liu P; Jiang Y; Lv S; Zeng F; Chen X; Wang S; Zhang H; Wu H; Zhang H; Ouyang L; Su X
Int J Oncol; 2016 Sep; 49(3):961-70. PubMed ID: 27315007
[TBL] [Abstract][Full Text] [Related]
34. PD-L1 Antibody Pharmacokinetics and Tumor Targeting in Mouse Models for Infectious Diseases.
Sandker GGW; Adema G; Molkenboer-Kuenen J; Wierstra P; Bussink J; Heskamp S; Aarntzen EHJG
Front Immunol; 2022; 13():837370. PubMed ID: 35359962
[TBL] [Abstract][Full Text] [Related]
35. CSPG4 as a target of antibody-based immunotherapy for malignant mesothelioma.
Rivera Z; Ferrone S; Wang X; Jube S; Yang H; Pass HI; Kanodia S; Gaudino G; Carbone M
Clin Cancer Res; 2012 Oct; 18(19):5352-63. PubMed ID: 22893632
[TBL] [Abstract][Full Text] [Related]
36. Imaging small human prostate cancer xenografts after pretargeting with bispecific bombesin-antibody complexes and targeting with high specific radioactivity labeled polymer-drug conjugates.
Patil V; Gada K; Panwar R; Varvarigou A; Majewski S; Weisenberger A; Ferris C; Tekabe Y; Khaw BA
Eur J Nucl Med Mol Imaging; 2012 May; 39(5):824-39. PubMed ID: 22302089
[TBL] [Abstract][Full Text] [Related]
37. IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses.
Finkelman FD; Katona IM; Mosmann TR; Coffman RL
J Immunol; 1988 Feb; 140(4):1022-7. PubMed ID: 3125247
[TBL] [Abstract][Full Text] [Related]
38. Clearance of IgE from serum of normal and hybridoma-bearing mice.
Haba S; Ovary Z; Nisonoff A
J Immunol; 1985 May; 134(5):3291-7. PubMed ID: 3980994
[TBL] [Abstract][Full Text] [Related]
39. Effect of antigen binding affinity and effector function on the pharmacokinetics and pharmacodynamics of anti-IgE monoclonal antibodies.
Mortensen DL; Prabhu S; Stefanich EG; Kadkhodayan-Fischer S; Gelzleichter TR; Baker D; Jiang J; Wallace K; Iyer S; Fielder PJ; Putnam WS
MAbs; 2012; 4(6):724-31. PubMed ID: 23778267
[TBL] [Abstract][Full Text] [Related]
40. Using the allergic immune system to target cancer: activity of IgE antibodies specific for human CD20 and MUC1.
Teo PZ; Utz PJ; Mollick JA
Cancer Immunol Immunother; 2012 Dec; 61(12):2295-309. PubMed ID: 22692757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
